Q2 2026 Holdings
Filed 2026-08-14 | 86 holdings | $2.7B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Caris Life Sciences Inc(CAI) | COM | 142152107 | $147.1M | 8,256,032 | 5.4% |
| Hinge Health Inc(HNGE) | CL A | 433313103 | $110.4M | 1,330,127 | 4.1% |
| Glaukos Corp(GKOS) | COM | 377322102 | $82.7M | 591,927 | 3.1% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $81.1M | 1,996,965 | 3.0% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $78.1M | 879,467 | 2.9% |
| Irhythm Holdings Inc(IRTC) | COM | 450056106 | $77.8M | 654,262 | 2.9% |
| Neogenomics Inc(NEO) | COM NEW | 64049M209 | $71.8M | 4,918,202 | 2.7% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $69.6M | 1,787,318 | 2.6% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $68.3M | 1,131,452 | 2.5% |
| Alphatec Hldgs Inc | NOTE 0.750% 3/1 | 02081GAD4 | $66.2M | $69,121,000 | 2.4% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $59.3M | 2,451,562 | 2.2% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $58.0M | 594,562 | 2.1% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $56.7M | 336,171 | 2.1% |
| Alphatec Hldgs Inc(ATEC) | COM NEW | 02081G201 | $56.5M | 6,531,439 | 2.1% |
| Generate Biomedicines Inc(GENB) | COM SHS | 370920100 | $55.4M | 3,283,844 | 2.0% |
| Maravai Lifesciences Hldgs I(MRVI) | COM CL A | 56600D107 | $54.3M | 8,702,921 | 2.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $47.9M | 128,975 | 1.8% |
| Humana Inc(HUM) | COM | 444859102 | $45.5M | 114,500 | 1.7% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $44.8M | 89,395 | 1.7% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $43.4M | 378,163 | 1.6% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $42.3M | 381,128 | 1.6% |
| Damora Therapeutics Inc(GLTO) | COM NEW | 36322Q206 | $42.1M | 1,620,377 | 1.6% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $41.7M | 1,646,399 | 1.5% |
| Brightspring Health Svcs Inc(BTSG) | COM | 10950A106 | $41.6M | 596,753 | 1.5% |
| Transmedics Group Inc(TMDX) | COM | 89377M109 | $40.5M | 609,715 | 1.5% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $39.2M | 710,880 | 1.5% |
| Climb BIO Inc(CLYM) | COM | 28658R106 | $36.5M | 2,797,375 | 1.3% |
| Caredx Inc(CDNA) | COM | 14167L103 | $34.8M | 1,220,602 | 1.3% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $34.0M | 1,140,040 | 1.3% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $34.0M | 483,822 | 1.3% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $33.7M | 1,141,477 | 1.2% |
| Nektar Therapeutics(NKTR) | COM NEW | 640268306 | $33.1M | 473,617 | 1.2% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $31.8M | 2,126,298 | 1.2% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $31.2M | 1,286,769 | 1.2% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $30.2M | 677,570 | 1.1% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $30.1M | 1,629,182 | 1.1% |
| Alamar Biosciences Inc(ALMR) | COMMON STOCK | 010911105 | $29.4M | 1,083,983 | 1.1% |
| Danaher Corp del(DHR) | COM | 235851102 | $28.7M | 150,627 | 1.1% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $27.9M | 70,137 | 1.0% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $26.5M | 278,164 | 1.0% |
| Avalyn Pharmaceuticals Inc(AVLN) | COM SHS | 05348Y105 | $26.4M | 801,395 | 1.0% |
| Aveanna Healthcare Hldgs Inc(AVAH) | COM | 05356F105 | $26.3M | 3,065,106 | 1.0% |
| Bioage Labs Inc(BIOA) | COM | 09077V100 | $25.3M | 1,033,129 | 0.9% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $25.1M | 587,567 | 0.9% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $24.2M | 564,724 | 0.9% |
| Repligen Corp(RGEN) | COM | 759916109 | $24.2M | 177,100 | 0.9% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $23.5M | 3,980,295 | 0.9% |
| Guardant Health Inc(GH) | COM | 40131M109 | $22.2M | 147,850 | 0.8% |
| Evolus Inc(EOLS) | COM | 30052C107 | $21.9M | 3,155,209 | 0.8% |
| Natera Inc(NTRA) | COM | 632307104 | $21.6M | 79,500 | 0.8% |